These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9610912)

  • 1. IL-3-mediated enhancement of particulate antigen presentation by macrophages.
    Lord EM; Yeh KY; Moran JA; Storozynsky E; Frelinger JG
    J Immunother; 1998 May; 21(3):205-10. PubMed ID: 9610912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.
    Yeh KY; McAdam AJ; Pulaski BA; Shastri N; Frelinger JG; Lord EM
    J Immunol; 1998 Jun; 160(12):5773-80. PubMed ID: 9637487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.
    Pulaski BA; Yeh KY; Shastri N; Maltby KM; Penney DP; Lord EM; Frelinger JG
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3669-74. PubMed ID: 8622994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
    Mitchell DA; Nair SK; Gilboa E
    Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
    Reis e Sousa C; Germain RN
    J Exp Med; 1995 Sep; 182(3):841-51. PubMed ID: 7650490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
    Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
    Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.
    Stagg J; Pommey S; Eliopoulos N; Galipeau J
    Blood; 2006 Mar; 107(6):2570-7. PubMed ID: 16293599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide.
    Chung SW; Cohen EP; Kim TS
    Vaccine; 2004 Jun; 22(20):2547-57. PubMed ID: 15193380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
    Chen W; Carbone FR; McCluskey J
    J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
    Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
    Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.